{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:34:45Z","timestamp":1787726085639,"version":"build-2784847793"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013061","name":"Jilin Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20230101136JC"],"award-info":[{"award-number":["20230101136JC"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070931"],"award-info":[{"award-number":["32070931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbi.2026.106486","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:38:29Z","timestamp":1770856709000},"page":"106486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Self-assembling ferritin nanoplatform enables amyloid-\u03b2-targeted immunotherapy and cognitive rescue in APP\/PS1 mice"],"prefix":"10.1016","volume":"135","author":[{"given":"Jiaxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2026.106486_b0005","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","article-title":"Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2","volume":"8","author":"Arndt","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2026.106486_b0010","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/s41467-024-54779-w","article-title":"Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer's Disease","volume":"15","author":"Balig\u00e1cs","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2026.106486_b0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13195-024-01492-x","article-title":"Age, sex and Alzheimer's disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients","volume":"16","author":"Barber","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2026.106486_b0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","article-title":"Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification","volume":"12","author":"Barthelemy","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2026.106486_b0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barthelemy","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2026.106486_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-023-00700-w","article-title":"Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner","volume":"19","author":"Bosch","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbi.2026.106486_b0035","doi-asserted-by":"crossref","first-page":"19234","DOI":"10.1038\/srep19234","article-title":"Plug-and-Display: decoration of Virus-like Particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2026.106486_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2023.1231706","article-title":"The dual face of microglia (M1\/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases","volume":"4","author":"Darwish","year":"2023","journal-title":"Front. Aging"},{"key":"10.1016\/j.bbi.2026.106486_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1326784","article-title":"Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications","volume":"18","author":"Doran","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2026.106486_b0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2042-6410-3-24","article-title":"Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition?","volume":"3","author":"Dubal","year":"2012","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.bbi.2026.106486_b0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-015-0108-3","article-title":"Long-term treatment with active Abeta immunotherapy with CAD106 in mild Alzheimer's disease","volume":"7","author":"Farlow","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2026.106486_b0060","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/17512433.2025.2556122","article-title":"Review of anti-amyloid-beta (Abeta) monoclonal antibodies for the treatment of Alzheimer's disease","volume":"18","author":"Francis","year":"2025","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bbi.2026.106486_b0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mad.2003.12.002","article-title":"Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta)","volume":"125","author":"Gandy","year":"2004","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbi.2026.106486_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124231","article-title":"A\u03b2-oligomers: a potential therapeutic target for Alzheimer's disease","volume":"239","author":"Ghosh","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbi.2026.106486_b0075","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2026.106486_b0080","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbi.2026.106486_b0085","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2026.106486_b0090","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-beta pathway in alzheimer's disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106486_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092129","article-title":"Catching a SPY: using the SpyCatcher-SpyTag and related systems for labeling and localizing bacterial proteins","volume":"20","author":"Hatlem","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2026.106486_b0100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/j.2040-4603.2016.tb00710.x","article-title":"Sex hormones and cognition: neuroendocrine influences on memory and learning","volume":"6","author":"Hamson","year":"2016","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbi.2026.106486_b0105","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.12659\/MSM.908765","article-title":"Micro-RNA-137 inhibits tau hyperphosphorylation in alzheimer's disease and targets the CACNA1C gene in transgenic mice and human neuroblastoma SH-SY5Y cells","volume":"24","author":"Jiang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bbi.2026.106486_b0110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12640-015-9589-x","article-title":"Sex Dimorphism profile of alzheimer's disease-type pathologies in an APP\/PS1 mouse model","volume":"29","author":"Jiao","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbi.2026.106486_b0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2026.106486_b0120","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","article-title":"Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates","volume":"15","author":"Kang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbi.2026.106486_b0125","doi-asserted-by":"crossref","first-page":"26523","DOI":"10.1073\/pnas.1909653116","article-title":"Approaching infinite affinity through engineering of peptide-protein interaction","volume":"116","author":"Keeble","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2026.106486_b0130","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2026.106486_b0135","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrn937","article-title":"Science and society: the psychiatric revolution: care in the community","volume":"3","author":"Leff","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2026.106486_b0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2026.106486_b0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jmb.2013.10.021","article-title":"Structural analysis and optimization of the covalent association between SpyCatcher and a peptide Tag","volume":"426","author":"Li","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbi.2026.106486_b0150","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","article-title":"Mechanisms of sex differences in Alzheimer's disease","volume":"112","author":"Lopez-Lee","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2026.106486_b0155","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1039\/C9NR08958F","article-title":"Nanoparticle formulated vaccines: opportunities and challenges","volume":"12","author":"Lung","year":"2020","journal-title":"Nanoscale"},{"issue":"1315\u20131330","key":"10.1016\/j.bbi.2026.106486_b0160","first-page":"e1319","article-title":"Nanoparticle vaccines based on the receptor binding domain (RBD) and Heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2026.106486_b0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neurobiolaging.2021.01.018","article-title":"Sex differences in the IntelliCage and the Morris water maze in the APP\/PS1 mouse model of amyloidosis","volume":"101","author":"Mifflin","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2026.106486_b0170","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2026.106486_b0175","first-page":"43","article-title":"Alzheimer's disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.bbi.2026.106486_b0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-023-02870-2","article-title":"Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer's disease","volume":"20","author":"Ocanas","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2026.106486_b0185","article-title":"Women and the risk of Alzheimer's disease","volume":"4","author":"O'Neal","year":"2023","journal-title":"Front Glob Womens Health"},{"key":"10.1016\/j.bbi.2026.106486_b0190","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/brain\/awab129","article-title":"Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys","volume":"144","author":"Patel","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2026.106486_b0195","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neubiorev.2015.09.002","article-title":"The problem of genotype and sex differences in life expectancy in transgenic AD mice","volume":"57","author":"Rae","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2026.106486_b0200","doi-asserted-by":"crossref","DOI":"10.1007\/s42399-021-01092-y","article-title":"Tau and Alzheimer\u2019s disease: molecular mechanisms and treatment approaches","volume":"4","author":"Reiss","year":"2021","journal-title":"SN Compr. Clin. Med."},{"key":"10.1016\/j.bbi.2026.106486_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2022.130288","article-title":"Ferritin nanocages as efficient nanocarriers and promising platforms for COVID-19 and other vaccines development","volume":"1867","author":"Reutovich","year":"2023","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bbi.2026.106486_b0210","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.90.22.10836","article-title":"beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease","volume":"90","author":"Roher","year":"1993","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2026.106486_b0215","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2026.106486_b0220","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910606","article-title":"Novel Alzheimer risk genes determine the microglia response to amyloid-beta but not to TAU pathology","volume":"12","author":"Sierksma","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbi.2026.106486_b0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2026.106486_b0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-020-00416-z","article-title":"Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer's disease","volume":"6","author":"Sun","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbi.2026.106486_b0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-023-00649-w","article-title":"Amyloid-beta (Abeta) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice","volume":"18","author":"Taylor","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbi.2026.106486_b0240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-animal-021419-083813","article-title":"Nonhuman primates in translational research","volume":"10","author":"Tarantal","year":"2022","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"10.1016\/j.bbi.2026.106486_b0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13024-024-00758-0","article-title":"Amyloid-beta (Abeta) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer's disease","volume":"19","author":"Taylor","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbi.2026.106486_b0250","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/s41380-022-01675-8","article-title":"Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression","volume":"27","author":"Tsiknia","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106486_b0255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2019.05.031","article-title":"Sex differences in Alzheimer's disease: understanding the molecular impact","volume":"1719","author":"Toro","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2026.106486_b0260","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-140741","article-title":"The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice","volume":"43","author":"Tucker","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2026.106486_b0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2026.106486_b0270","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1002\/alz.14038","article-title":"Plasma and CSF biomarkers of aging and cognitive decline in Caribbean vervets","volume":"20","author":"Varma","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2026.106486_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043895","article-title":"Alzheimer's disease: a brief history of immunotherapies targeting amyloid beta","volume":"24","author":"Vogt;","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2026.106486_b0280","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.trci.2017.03.005","article-title":"UB-311, a novel UBITh((R)) amyloid beta peptide vaccine for mild Alzheimer's disease","volume":"3","author":"Wang","year":"2017","journal-title":"Alzheimers Dement (n y)"},{"key":"10.1016\/j.bbi.2026.106486_b0285","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.4049\/jimmunol.166.12.7496","article-title":"Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q","volume":"166","author":"Webster","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2026.106486_b0290","first-page":"11","article-title":"Microglia phenotypes in aging and neurodegenerative diseases","author":"Wendimu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2026.106486_b0295","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1523\/JNEUROSCI.0293-11.2011","article-title":"The second-generation active Abeta immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects","volume":"31","author":"Wiessner","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2026.106486_b0300","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active Abeta immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2026.106486_b0305","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/jnen\/nly059","article-title":"beta-amyloid induces pathology-related patterns of tau hyperphosphorylation at synaptic terminals","volume":"77","author":"Wu","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbi.2026.106486_b0310","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12264-018-0268-9","article-title":"Sex differences in neuropathology and cognitive behavior in APP\/PS1\/tau triple-transgenic mouse model of alzheimer's disease","volume":"34","author":"Yang","year":"2018","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bbi.2026.106486_b0315","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1074\/jbc.R800018200","article-title":"Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease","volume":"284","author":"Yankner","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2026.106486_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104665","article-title":"Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"94","author":"Yu","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbi.2026.106486_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103207","article-title":"Synthetic amyloid-beta oligomers drive early pathological progression of Alzheimer's disease in nonhuman primates","volume":"24","author":"Yue","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.bbi.2026.106486_b0330","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2026.106486_b0335","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt211","article-title":"The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation","volume":"5","author":"Zhang","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2026.106486_b0340","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1021\/acs.nanolett.9b02834","article-title":"Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.bbi.2026.106486_b0345","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fnagi.2018.00243","article-title":"Sex differences in the white matter and myelinated fibers of APP\/PS1 mice and the effects of running exercise on the sex differences of AD mice","volume":"10","author":"Zhou","year":"2018","journal-title":"Front. Aging Neurosci."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126002345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126002345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:31:58Z","timestamp":1781062318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126002345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":69,"alternative-id":["S0889159126002345"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106486","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembling ferritin nanoplatform enables amyloid-\u03b2-targeted immunotherapy and cognitive rescue in APP\/PS1 mice","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106486"}}